ESCAPE Bio Company

ESCAPE Bio is a clinical-stage biopharmaceutical company that develops small molecule drugs intended to treat neurodegenerative diseases.
Industry: Biotechnology, Health Care, Medical
Headquarters: South San Francisco, California, United States
Founded Date: 2015
Employees Number: 11-50
Investors Number: 14
Total Funding: 187076080
Estimated Revenue: $10M to $50M
Last Funding Date: 2020
Last Funding Type: Venture - Series Unknown

Visit Website
info@escapebio.com
Register and Claim Ownership